STORY
1 day 5 outlets 5 reports running since 09.11

LATEST

GLP-1 drugs may increase risk of vision loss from rare condition, FDA warns
arstechnica.com  ·  10.11.2026 15:43

HOW IT DEVELOPED

  1. Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn theguardian.com  ·  10.11 14:00
  2. FDA orders blindness risk warning on weight loss drugs news.sky.com  ·  10.11 01:24
  3. FDA Orders New Vision Loss Warning for Ozempic, Wegovy, Mounjaro and Zepbound mensjournal.com  ·  09.11 21:19
  4. Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss marketwatch.com  ·  09.11 18:52

More in this section

Seagate's new hybrid drive raises some old questionsarstechnica.com · 11.11 The US military seems to be getting nervous about the launch supply cruncharstechnica.com · 11.11 Ring cameras go mobile as Amazon debuts AI-powered security drone and robotarstechnica.com · 10.11 Democrats oppose plan to stack FCC with Republicans, plan probes of Chairman Carrarstechnica.com · 10.11 Grok Build coding agent leaks oodles of confidential info, some belonging to SpaceXSIarstechnica.com · 10.11 OpenAI Acquires Odessia, travel startup created by Sonder foundertechcrunch.com · 10.11

Other stories

Scientists anchor first scientific animal name to a modern-day spiderscience · phys.org Zelenski Ukraynanın Rusiya ilə razılaşma müqabilində Donbası verməyəcəyini bildiribazerbaijan · apa.az Elliot Frances Flynn and Michael Paré to Star in Indie Supernatural Horror ‘Not Herself’ (EXCLUSIVE)culture · variety.com İspaniyada 24 saatlıq ümumi tətil keçiriləcəkazerbaijan · apa.az Miami (OH) vs. Ohio prediction, picks, odds, start time: Betting preview for college football, Nov. 10sport · cbssports.com ABŞ Nümayəndələr Palatası Pit Heqsetin impiçmenti təşəbbüsünü bloklayıbazerbaijan · report.az